149 related articles for article (PubMed ID: 6301764)
1. Hemodynamic responses to beta-adrenergic blockade with metoprolol and pindolol after coronary artery bypass surgery.
Salmenperä M; Yrjölä H; Heikkilä J
Chest; 1983 May; 83(5):739-43. PubMed ID: 6301764
[TBL] [Abstract][Full Text] [Related]
2. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
Svendsen TL
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
[TBL] [Abstract][Full Text] [Related]
3. Cardiac safety of acute beta blockade: intrinsic sympathomimetic activity is superior to beta-1 selectivity.
Heikkilä J; Nieminen MS
Am Heart J; 1982 Aug; 104(2 Pt 2):464-72. PubMed ID: 7102533
[TBL] [Abstract][Full Text] [Related]
4. Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.
Silke B; Frais MA; Verma SP; Reynolds G; Taylor SH
Eur J Clin Pharmacol; 1986; 29(6):659-65. PubMed ID: 2872054
[TBL] [Abstract][Full Text] [Related]
5. Mode of action of beta-adrenoceptor blocking agents in hypertension. A comparison between metoprolol and pindolol with special reference to peripheral vascular effects.
Svensson A; Gudbrandsson T; Sivertsson R; Hansson L
Acta Med Scand Suppl; 1982; 665():103-8. PubMed ID: 6760678
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamics of metoprolol and pindolol in systemic hypertension with particular reference to reversal of structural vascular changes.
Hansson L
Am J Cardiol; 1986 Feb; 57(5):29C-32C. PubMed ID: 3946248
[TBL] [Abstract][Full Text] [Related]
7. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?
Taylor SH; Silke B; Lee PS
N Engl J Med; 1982 Mar; 306(11):631-5. PubMed ID: 6120457
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
[TBL] [Abstract][Full Text] [Related]
9. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
Prida XE; Feldman RL; Hill JA; Pepine CJ
Am J Cardiol; 1987 Aug; 60(4):244-8. PubMed ID: 2887101
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of pindolol.
Aellig WH
Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of beta-adrenoceptor blocking drugs possessing partial agonist activity, with special reference to pindolol.
Aellig WH
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S16-20. PubMed ID: 6188915
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of intravenous metoprolol.
Bourdillon PD; Canepa-Anson R; Rickards AF
Am J Cardiol; 1979 Nov; 44(6):1195-200. PubMed ID: 495515
[TBL] [Abstract][Full Text] [Related]
13. Effects of pindolol and metoprolol on plasma lipids and lipoproteins.
Pasotti C; Capra A; Fiorella G; Vibelli C; Chierichetti SM
Br J Clin Pharmacol; 1982; 13(Suppl 2):435S-439S. PubMed ID: 7104157
[TBL] [Abstract][Full Text] [Related]
14. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute beta-adrenergic receptor desensitization during cardiac surgery?
Booth JV; Ward EE; Colgan KC; Funk BL; El-Moalem H; Smith MP; Milano C; Smith PK; Newman MF; Schwinn DA;
Anesth Analg; 2004 May; 98(5):1224-31, table of contents. PubMed ID: 15105192
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic differences between beta blockers.
Wood AJ
Am Heart J; 1984 Oct; 108(4 Pt 2):1070-7. PubMed ID: 6148865
[TBL] [Abstract][Full Text] [Related]
16. Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
Ades PA; Wolfel EE; Hiatt WR; Fee C; Rolfs R; Brammell HL; Horwitz LD
Eur J Clin Pharmacol; 1989; 36(1):5-10. PubMed ID: 2917588
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypertension with beta-blockers with and without intrinsic sympathomimetic activity.
Hansson L; Svensson A; Gudbrandsson T; Sivertsson R
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S26-9. PubMed ID: 6188917
[TBL] [Abstract][Full Text] [Related]
18. Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).
Erikssen J; Thaulow E; Mundal R; Opstad P; Nitter-Hauge S
Br J Clin Pharmacol; 1982; 13(Suppl 2):201S-209S. PubMed ID: 6125171
[TBL] [Abstract][Full Text] [Related]
19. Clinical, electrocardiographic, and hemodynamic effects of ICI 89,406, a new cardioselective beta-adrenoceptor antagonist with intrinsic sympathomimetic activity, in patients with angina pectoris.
Majid PA; Schreuder JE; de Feyter PJ; Roos JP
J Cardiovasc Pharmacol; 1980; 2(4):435-44. PubMed ID: 6156341
[TBL] [Abstract][Full Text] [Related]
20. Comparative clinical and hemodynamic investigations on two beta-receptor blocking agents (pindolol and mepindolol) in normal subjects.
Wink K
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):126-30. PubMed ID: 6715080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
